Cargando…
Remdesivir: A Review in COVID-19
Remdesivir (Veklury(®)), a nucleotide analogue prodrug with broad-spectrum antiviral activity, is approved for the treatment of coronavirus disease 2019 (COVID-19), the illness caused by severe acute respiratory syndrome coronavirus 2 infection. Unlike some antivirals, remdesivir has a low potential...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474216/ https://www.ncbi.nlm.nih.gov/pubmed/37589788 http://dx.doi.org/10.1007/s40265-023-01926-0 |